Stock ScreenerStock IdeasStock ForecastsStock Predictions & Stock Market Forecast 2026, 2027, 2028, 2029, 2030View analyst forecasts, price targets, buy/sell ratings, revenue/earnings forecasts and more
Stock ScreenerStock IdeasStock Forecasts
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| DSC | DSC HOLDINGS LTD | N/A | 1,001,449,847 | 0.00% | 43.09% | ||||
| CATLU | CATALYST ACQUISITION CORP | N/A | 25,270,000 | 0.00% | 1.07% | Net Buying | Net Buying | ||
| FJDIU | ARC GROUP SECURITIES ACQUISITION I | N/A | 15,560,000 | 0.00% | 0.06% | ||||
| MTAKU | MARKET TECHNOLOGY ACQUISITION CORP | N/A | 27,366,667 | 0.00% | 3.31% | Net Buying | Net Buying | ||
| BIOT | INSTINCT BIO TECHNICAL CO INC | N/A | 28,753,850 | 0.00% | 0.00% | ||||
| NUR | NURAN WIRELESS INC | N/A | 13,084,716 | 0.00% | 0.00% | ||||
| BREZ | BREEZE ACQUISITION CORP II | N/A | 17,689,392 | 0.08% | 60.14% | ||||
| THEO | BOA ACQUISITION CORP II | N/A | 18,078,643 | 0.00% | 0.00% | ||||
| IMC | IMC RARE EARTHS LTD | N/A | 105,100,000 | 0.00% | 66.60% | ||||
| NSAIU | NORTHSTRIVE ACQUISITION CORP I | N/A | 14,431,750 | 0.00% | 0.00% | ||||
| SCTX | SCRIBE THERAPEUTICS INC | N/A | 16,182,010 | 0.00% | 71.65% | Net Buying | Net Buying | ||
| SNSC | SUNSCOUT HOLDING LTD | N/A | 39,000,000 | 0.00% | 43.90% | ||||
| REF | REFORMATION INC | N/A | 59,076,208 | 0.00% | 100.00% | Net Selling | Net Selling | ||
| ATTO | ATTOVIA THERAPEUTICS INC | N/A | 43,029,017 | 0.00% | 66.07% | Net Buying | Net Buying | ||
| PNAQ.U | PINNACLE ACQUISITION CORP | N/A | 25,225,000 | 0.00% | 12.80% | Net Buying | Net Buying | ||
| JMKE | JERSEY MIKE's SUBS INC | N/A | 317,638,900 | 0.00% | 54.87% | Net Selling | Net Selling | ||
| PHOS | FIRST PHOSPHATE CORP | N/A | 179,947,950 | 0.00% | 0.00% | ||||
| IOND | IONIC DIGITAL INC | N/A | 37,374,261 | 0.00% | 0.00% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.